Procedure
Splenectomy
Splenectomy is a medical procedure with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
Recruiting2
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
completed120%
recruiting240%
unknown240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingnot_applicable
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT07080697
recruiting
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
NCT03998059
unknown
Microbiota is Related With Increasing Infection Rates After Splenectomy
NCT03420599
completed
Splenectomy During Whole Liver Transplantation
NCT03609411
unknownphase_2
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
NCT02862054
Clinical Trials (5)
Showing 5 of 5 trials
NCT07080697Not Applicable
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT03998059
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
NCT03420599
Microbiota is Related With Increasing Infection Rates After Splenectomy
NCT03609411
Splenectomy During Whole Liver Transplantation
NCT02862054Phase 2
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
All 5 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 5